We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00822224
First Posted: January 14, 2009
Last Update Posted: December 9, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Fondation de France
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice
  Purpose

Acute pain is frequent in elderly especially in geriatrics acute care units where painful procedures are often occurring.

MEOPA represents an alternative to opioïd therapy to prevent procedural pain during the treatment of pressure ulcers.

In this study, cognitive impairment and dementia do not limit the use of MEOPA. The new approach in the management of acute procedural pain provides effective and safe analgesia in frail old patients.


Condition Intervention
Dementia Drug: MEOPA

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Use of MEOPA for Elderly With Dementia.

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire de Nice:

Primary Outcome Measures:
  • feasibility of use of MEOPA as tolerance to mask, MEOPA inhalation [ Time Frame: one time, at the first care with MEOPA ]

Secondary Outcome Measures:
  • satisfaction rate of patient [ Time Frame: one time, at the first care with MEOPA ]

Estimated Enrollment: 50
Study Start Date: January 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Use of MEOPA during the painful care
Drug: MEOPA
inhalation of MEOPA during the painful care

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   75 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • dementia (Folstein scoring between 0 and 25)
  • older than 75
  • health necessitating of painful care for example eschar care

Exclusion Criteria:

  • bullous emphysema
  • pneumothorax
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00822224


Locations
France
Gerontology department, Nice University Hospital
Nice, France, 06000
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Fondation de France
Investigators
Principal Investigator: Françoise CAPRIZ-RIBIERE, PhD Gerontology department, Nice University Hospital
  More Information

Responsible Party: Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier: NCT00822224     History of Changes
Other Study ID Numbers: 08-PP-03
First Submitted: January 13, 2009
First Posted: January 14, 2009
Last Update Posted: December 9, 2011
Last Verified: December 2011

Keywords provided by Centre Hospitalier Universitaire de Nice:
acute pain
MEOPA
Dementia

Additional relevant MeSH terms:
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders